Doxorubicin liposome Intravenous and Empagliflozin and metformin
Determining the interaction of Doxorubicin liposome Intravenous and Empagliflozin and metformin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox, Lipodox 50
Synonyms: Doxorubicin liposomal, DOXOrubicin (Liposomal)
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doxorubicin liposome Intravenous-Empagliflozin and Metformin Extended-Release Tablets
- Doxorubicin liposome Intravenous-Empagliflozin and Metformin Tablets
- Doxorubicin liposome Intravenous-Empliciti
- Doxorubicin liposome Intravenous-Emsam
- Doxorubicin liposome Intravenous-Emsam Transdermal
- Doxorubicin liposome Intravenous-Emtricitabine
- Empagliflozin and metformin-Doxy 100
- Empagliflozin and metformin-Doxycycline
- Empagliflozin and metformin-Doxycycline Calcium
- Empagliflozin and metformin-Doxycycline Capsules (Rosacea)
- Empagliflozin and metformin-Doxycycline Capsules with Omega-3 and Vitamin E Capsules
- Empagliflozin and metformin-Doxycycline Delayed Release Capsule